Fidasimtamab [2377419-89-9]

TargetMol Chemicals

Fidasimtamab

9

2377419-89-9

Antibody

Research Use Only

Fidasimtamab

Fidasimtamab (IBI-315; BH2950), a recombinant human IgG1 bispecific antibody, specifically targets, binds to, and inhibits HER2 and PD-1 along with their downstream signaling pathways. Additionally, it bridges PD-1 expressing T cells with HER2 expressing tumor cells, demonstrating potential immunosuppressive and antitumor activities [1].

3 years

-20°C

12352203